Updated Jun 1, 2026 by Remedy Entertainment
Remedy Entertainment achieved a profitable Q1 2026 with an operating profit of EUR 1.0 million (7.8% margin) and EBITDA of EUR 2.9 million, despite a 1.9% year-over-year revenue decline to EUR 13.1 million.
Operational cash flow improved significantly to EUR 8.3 million, contributing to a strong balance sheet with a net cash position of EUR 14.4 million and an equity ratio of 68.6%.
Revenue was supported by royalties from Alan Wake 2 and the launch of FBC: Firebreak, alongside development fees from the Max Payne 1&2 remake and CONTROL Resonant.
The company is pursuing a self-publishing strategy with a long-term goal to double 2024 revenue by 2027 while achieving a 30% EBITDA margin.
Headcount grew by 4.8% to 391 employees, driving a 5.1% increase in personnel expenses, while materials and services costs were reduced by 52.5%.
Remedy is intensifying marketing efforts for the upcoming launch of CONTROL Resonant, specifically targeting expansion into Chinese and Latin American markets.
Remedy Entertainment achieved a profitable Q1 2026 with an operating profit of EUR 1.0 million (7.8% margin) and EBITDA of EUR 2.9 million, despite a 1.9% year-over-year revenue decline to EUR 13.1 million.
Operational cash flow improved significantly to EUR 8.3 million, contributing to a strong balance sheet with a net cash position of EUR 14.4 million and an equity ratio of 68.6%.
Revenue was supported by royalties from Alan Wake 2 and the launch of FBC: Firebreak, alongside development fees from the Max Payne 1&2 remake and CONTROL Resonant.
The company is pursuing a self-publishing strategy with a long-term goal to double 2024 revenue by 2027 while achieving a 30% EBITDA margin.
Headcount grew by 4.8% to 391 employees, driving a 5.1% increase in personnel expenses, while materials and services costs were reduced by 52.5%.
Remedy is intensifying marketing efforts for the upcoming launch of CONTROL Resonant, specifically targeting expansion into Chinese and Latin American markets.